FindTrial
Sign In

Perimenopause in diabetic and non diabetic women

Assessment of Metabolic Syndrome and Quality of Life in Perimenopausal Women with or without Diabetes Mellitus - NIL

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2025/04/085701
Enrollment
257
Registered
2025-04-25
Start date
Unknown
Completion date
Unknown
Last updated
2025-10-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N959- Unspecified menopausal and perimenopausal disorder

Interventions

Intervention1: Nil: Nil Intervention2: Nil: Nil

Sponsors

NAZIJA MPC
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Perimenopausal women in the age group of 40-55 years

Exclusion criteria

Exclusion criteria: 1. Pregnant women and lactating mothers 2. Women with cardiovascular and cerebrovascular diseases 3. Women with lung disease, renal failure, liver disease or other terminal illnesses 4. Patients receiving hormone replacement therapy 5. Patients not willing to participate in the study

Design outcomes

Primary

MeasureTime frame
Benefit to Perimenopause womenTimepoint: Baseline—

Secondary

MeasureTime frame
Improved healthcare for perimenopause womenTimepoint: at the end of the study—

Countries

India

Contacts

Public ContactNAZIJA MPC

Yenepoya Pharmacy College and Research Centre

treesap@yenepoya.edu.in9496656112

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026